INOVA DIAGNOSTICS , INC.
- Shared products
- ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTICORPO ANTINUCLEAR (ANA), ANTICORPO PARA DOENÇA CELÍACA, ANTINUCLEAR ANTIBODY (ANA), AUTOIMMUNE HEPATITIS (AIH) ANTIBODY, FATOR REUMATÓIDE, SYSTEMIC LUPUS ERYTHEMATOSUS
- Shared products
- ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTINUCLEAR ANTIBODY (ANA), AUTOIMMUNE HEPATITIS (AIH) ANTIBODY, RHEUMATOID FACTOR, SYSTEMIC LUPUS ERYTHEMATOSUS
- Shared products
- ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTINUCLEAR ANTIBODY (ANA), AUTOIMMUNE HEPATITIS (AIH) ANTIBODY, SYSTEMIC LUPUS ERYTHEMATOSUS
- Shared products
- ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTINUCLEAR ANTIBODY (ANA), RHEUMATOID FACTOR
- Shared products
- ANTIBODY FOR CELIAC DISEASE, ANTINUCLEAR ANTIBODY (ANA), AUTOIMMUNE HEPATITIS (AIH) ANTIBODY, RHEUMATOID FACTOR, SYSTEMIC LUPUS ERYTHEMATOSUS
Explore comprehensive manufacturer profile for INOVA DIAGNOSTICS , INC. based in United States through Pure Global AI's free Brazil medical device database. This manufacturer has 17 products registered with ANVISA across 7 unique technical categories. Their regulatory history spans from Sep 24, 2009 to Apr 13, 2015.
This page provides detailed insights including 5 recent product registrations including ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP), 5 most popular products with ANTICORPO ANTINUCLEAR (ANA) having 4 registrations, 1 registration holders including WERFEN MEDICAL LTDA, and 5 key competitors with INOVA DIAGNOSTICS, INC. sharing 9 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.